rs2239611
|
|
|
0.010 |
GeneticVariation |
BEFREE |
These findings suggested that rs2284749 and rs2239611 in the ST6GAL1 gene are associated with lung carcinoma risk in the Chinese Han population.
|
31794515 |
2020 |
rs2284749
|
|
|
0.010 |
GeneticVariation |
BEFREE |
These findings suggested that rs2284749 and rs2239611 in the ST6GAL1 gene are associated with lung carcinoma risk in the Chinese Han population.
|
31794515 |
2020 |
rs2151280
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This hospital-based case-control study suggested that CDKN2B-AS1 rs2151280 T>C was associated with the risk of lung cancer.
|
31775885 |
2019 |
rs1800469
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The TGF-β1 T + 869C (rs1982073) and C-509T (rs1800469</span>) polymorphisms are not implicated in lung cancer susceptibility in the overall population.
|
31764821 |
2019 |
rs1982073
|
|
|
0.020 |
GeneticVariation |
BEFREE |
The TGF-β1 T + 869C (rs1982073) and C-509T (rs1800469) polymorphisms are not implicated in lung cancer susceptibility in the overall population.
|
31764821 |
2019 |
rs121434569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Of the 12 cases of NTRK1+ lung cancer, 6 had had concurrent activating EGFR mutations and/or had received previous treatment with EGFR tyrosine kinase inhibitors (TKIs), with 2 having concurrent EGFR T790M and 1 additional EGFR C797S.
|
31761448 |
2019 |
rs512715
|
|
|
0.010 |
GeneticVariation |
BEFREE |
However, the study showed that negative correlation the lung cancer risk and rs512715 polymorphisms.
|
31704150 |
2019 |
rs1042711
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Genetic model analysis shows that rs1042711 and rs1560642 were associated with increased risk of lung cancer; whereas rs7025417, rs5756523, and rs2284033 were associated with decreased disease risk (p < 0.05).
|
31685439 |
2019 |
rs1560642
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Genetic model analysis shows that rs1042711 and rs1560642 were associated with increased risk of lung cancer; whereas rs7025417, rs5756523, and rs2284033 were associated with decreased disease risk (p < 0.05).
|
31685439 |
2019 |
rs5756523
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Stratification analysis showed that rs1042711 and rs1560642 were associated with increased risk of lung cancer i</span>n nonsmokers and smokers, respectively, whereas rs7025417 and rs5756523 were associated with decreased disease risk in both subgroups (p<0.05).
|
31685439 |
2019 |
rs7025417
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Genetic model analysis shows that rs1042711 and rs1560642 were associated with increased risk of lung c</span>ancer; whereas rs7025417, rs5756523, and rs2284033 were associated with decreased disease risk (p < 0.05).
|
31685439 |
2019 |
rs121913530
|
|
|
0.880 |
GeneticVariation |
BEFREE |
We developed an integrative pharmacogenomics analysis to identify potential drug targets to overcome MEK/ERK inhibitor resistance in lung cancer cell lines with KRAS(G12C) mutation (n = 12).
|
31668570 |
2019 |
rs1801133
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In conclusion, this meta-analysis indicated that <i>MTRR</i> rs1801394 was significantly associated with LC in smokers, and <i>MTHFR</i> rs1801133 polymorphisms was also significantly associated with LC in smokers and East Asians.
|
31661627 |
2019 |
rs1801394
|
|
|
0.040 |
GeneticVariation |
BEFREE |
In conclusion, this meta-analysis indicated that <i>MTRR</i> rs1801394</span> was significantly associated with LC in smokers, and <i>MTHFR</i> rs1801133 polymorphisms was also significantly associated with LC in smokers and East Asians.
|
31661627 |
2019 |
rs121434569
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Its clinical utility has been well demonstrated for EGFR T790M testing in lung cancer patients suffering progress after tyrosine kinase inhibitor treatment.
|
31620244 |
2019 |
rs4513061
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Significant impact was not observed between the rs4513061 polymorphism and survival time of lung cancer.
|
31603707 |
2019 |
rs13181
|
|
|
0.800 |
GeneticVariation |
BEFREE |
We investigated associations between the risk of lung cancer in residents of the coal-mining region and polymorphisms in the genes APEX1 (rs1130409), hOGG1 (rs1052133), XRCC1 (rs25489, rs25487), XRCC2 (rs3218536), XRCC3 (rs861539), ADPRT/PARP1 (rs1136410), XPD/ERCC2 (rs13181), XPG/ERCC5 (rs17655), XPC (rs2228001), ATM (rs1801516), and NBS1 (rs1805794).
|
31584889 |
2019 |
rs1052133
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Using the multifactor dimensionality reduction method, we found a model of gene-gene interactions associated with the risk of lung cancer: NBS1 (rs1805794)-XRCC1 (rs25487)-hOGG1 (rs1052133)-XPG (rs17655).
|
31584889 |
2019 |
rs1130409
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We investigated associations between the risk of lung cancer in residents of the coal-mining region and polymorphisms in the genes APEX1 (rs1130409), hOGG1 (rs1052133), XRCC1 (rs25489, rs25487), XRCC2 (rs3218536), XRCC3 (rs861539), ADPRT/PARP1 (rs1136410), XPD/ERCC2 (rs13181), XPG/ERCC5 (rs17655), XPC (rs2228001), ATM (rs1801516), and NBS1 (rs1805794).
|
31584889 |
2019 |
rs25487
|
|
|
0.100 |
GeneticVariation |
BEFREE |
Using the multifactor dimensionality reduction method, we found a model of gene-gene interactions associated with the risk of lung cancer: NBS1 (rs1805794)-XRCC1 (rs25487)-hOGG1 (rs1052133)-XPG (rs17655).
|
31584889 |
2019 |
rs25489
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We investigated associations between the risk of lung cancer in residents of the coal-mining region and polymorphisms in the genes APEX1 (rs1130409), hOGG1 (rs1052133), XRCC1 (rs25489, rs25487), XRCC2 (rs3218536), XRCC3 (rs861539), ADPRT/PARP1 (rs1136410), XPD/ERCC2 (rs13181), XPG/ERCC5 (rs17655), XPC (rs2228001), ATM (rs1801516), and NBS1 (rs1805794).
|
31584889 |
2019 |
rs861539
|
|
|
0.100 |
GeneticVariation |
BEFREE |
We investigated associations between the risk of lung cancer in residents of the coal-mining region and polymorphisms in the genes APEX1 (rs1130409), hOGG1 (rs1052133), XRCC1 (rs25489, rs25487), XRCC2 (rs3218536), XRCC3 (rs861539), ADPRT/PARP1 (rs1136410), XPD/ERCC2 (rs13181), XPG/ERCC5 (rs17655), XPC (rs2228001), ATM (rs1801516), and NBS1 (rs1805794).
|
31584889 |
2019 |
rs17655
|
|
|
0.070 |
GeneticVariation |
BEFREE |
Using the multifactor dimensionality reduction method, we found a model of gene-gene interactions associated with the risk of lung cancer: NBS1 (rs1805794)-XRCC1 (rs25487)-hOGG1 (rs1052133)-XPG (rs17655).
|
31584889 |
2019 |
rs2228001
|
|
|
0.070 |
GeneticVariation |
BEFREE |
We investigated associations between the risk of lung cancer in residents of the coal-mining region and polymorphisms in the genes APEX1 (rs1130409), hOGG1 (rs1052133), XRCC1 (rs25489, rs25487), XRCC2 (rs3218536), XRCC3 (rs861539), ADPRT/PARP1 (rs1136410), XPD/ERCC2 (rs13181), XPG/ERCC5 (rs17655), XPC (rs2228001), ATM (rs1801516), and NBS1 (rs1805794).
|
31584889 |
2019 |
rs1805794
|
|
|
0.060 |
GeneticVariation |
BEFREE |
Using the multifactor dimensionality reduction method, we found a model of gene-gene interactions associated with the risk of lung cancer: NBS1 (rs1805794)-XRCC1 (rs25487)-hOGG1 (rs1052133)-XPG (rs17655).
|
31584889 |
2019 |